Gt Biopharma logo

Gt Biopharma Share Price (NASDAQ: GTBP)

$1.1

0.03

(2.8%)

Last updated on

Check the interactive Gt Biopharma Stock chart to analyse performance

Gt Biopharma stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$1.10
    Today's High:$1.13

    Day's Volatility :2.65%

  • 52 Weeks Low:$0.96
    52 Weeks High:$4.10

    52 Weeks Volatility :76.59%

Gt Biopharma Stock Returns

PeriodGt Biopharma IncSector (Health Care)Index (Russel 2000)
3 Months
-61.94%
6.0%
0.0%
6 Months
-45.81%
-5.6%
0.0%
1 Year
-49.07%
-11.1%
0.0%
3 Years
-98.58%
6.8%
-7.8%

Gt Biopharma Inc Key Stats

Check Gt Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.07
Open
$1.12
Today's High
$1.13
Today's Low
$1.1
Market Capitalization
$3.5M
Today's Volume
$96.2K
52 Week High
$4.1
52 Week Low
$0.96
Revenue TTM
$0.0
EBITDA
$-6.8M
Earnings Per Share (EPS)
$-3.98
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-181.99%

Stock Returns calculator for Gt Biopharma Stock including INR - Dollar returns

The Gt Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gt Biopharma investment value today

Current value as on today

₹55,242

Returns

₹44,758

(-44.76%)

Returns from Gt Biopharma Stock

₹49,074 (-49.07%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Gt Biopharma Stock

-25%

Period: Jul 24, 2025 to Aug 23, 2025. Change in 30 Days versus previous period

Search interest for Gt Biopharma Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Gt Biopharma Inc

  • Name

    Holdings %

  • Geode Capital Management, LLC

    0.71%

  • Citadel Advisors Llc

    0.62%

  • BMO Capital Markets Corp.

    0.45%

  • Bank of Montreal

    0.45%

  • Vanguard Group Inc

    0.32%

  • Wells Fargo & Co

    0.31%

Analyst Recommendation on Gt Biopharma Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Gt Biopharma(by analysts ranked 0 to 5 stars)

Gt Biopharma Share Price Target

What analysts predicted

Upside of 900.0%

Target:

$11.00

Current:

$1.10

Gt Biopharma share price target is $11.00, a slight Upside of 900.0% compared to current price of $1.10 as per analysts' prediction.

Gt Biopharma Stock Insights

  • Price Movement

    In the last 7 days, GTBP stock has moved down by -17.9%
  • GTBP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 115.9%
  • GTBP vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 109.5% return, outperforming this stock by 208.1%

Gt Biopharma Technicals Summary

Sell

Neutral

Buy

Gt Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Gt Biopharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Gt Biopharma Inc logo
-46.6%
-45.81%
-49.07%
-98.58%
528.57%
Regeneron Pharmaceuticals, Inc. logo
4.66%
-17.37%
-50.86%
-2.39%
-3.46%
Beone Medicines Ltd logo
7.62%
21.35%
57.45%
78.28%
25.05%
Vertex Pharmaceuticals Incorporated logo
-15.87%
-17.97%
-18.14%
35.67%
45.07%
Alnylam Pharmaceuticals, Inc. logo
38.16%
82.49%
68.79%
112.36%
238.79%

About Gt Biopharma Inc

GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms. It develops GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550 that targets B7-H3 on the surface of advanced solid tumors; and GTB-7550, a product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California.
Organization
Gt Biopharma
Employees
1
CEO
Mr. Michael Martin Breen L.L.B.
Industry
Pharmaceuticals: Other

Key Management of Gt Biopharma Inc

NameTitle
Mr. Michael Martin Breen L.L.B.
CEO & Executive Chairman
Mr. Alan Louis Urban CPA
CFO & Secretary

Important FAQs about investing in GTBP Stock from India :

What is Gt Biopharma share price today?

Gt Biopharma share price today is $1.10 as on at the close of the market. Gt Biopharma share today touched a day high of $1.13 and a low of $1.10.

What is the 52 week high and 52 week low for Gt Biopharma share?

Gt Biopharma share touched a 52 week high of $4.10 and a 52 week low of $0.96. Gt Biopharma stock price today i.e. is closed at $1.10, lower by 73.17% versus the 52 week high.

How to invest in Gt Biopharma Stock (GTBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gt Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gt Biopharma Shares that will get you 1.3636 shares as per Gt Biopharma share price of $1.10 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Gt Biopharma Stock (GTBP) from India?

Indian investors can start investing in Gt Biopharma (GTBP) shares with as little as ₹87.521 or $1 (as of August 24, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Gt Biopharma stock (as per the Rupee-Dollar exchange rate as on August 24, 2025). Based on Gt Biopharma share’s latest price of $1.10 as on August 23, 2025 at 1:29 AM IST, you will get 9.0909 shares of Gt Biopharma. Learn more about fractional shares .

What are the returns that Gt Biopharma has given to Indian investors in the last 5 years?

Gt Biopharma stock has given 528.57% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?